The Immunomodulatory Role of Vitamin D in Obesity
Open Access
- 20 May 2026
- journal article
- Published by Walter de Gruyter GmbH in Biuletyn Głównej Biblioteki Lekarskiej
- Vol. 59 (386) , 17-32
Abstract
Background: Obesity is fundamentally characterized by low-grade chronic inflammation (LGCI), driven by hypertrophic adipocytes and macrophage infiltration that release pro-inflammatory cytokines (e.g., TNF-α, IL-6). Vitamin D, recognized as a potent immunomodulator, holds significant potential in mitigating this inflammatory cascade. This review evaluates the impact of vitamin D supplementation on the pro-inflammatory cytokine profile and metabolic parameters in patients with obesity and metabolic syndrome. Methods: A comprehensive literature review was conducted using PubMed and Google Scholar databases. The analysis encompassed 31 scientific articles, including recent meta-analyses and randomized controlled trials (RCTs), focusing on the interplay between vitamin D, systemic inflammation, and obesity-related metabolic disturbances. Results: Current evidence indicates that vitamin D supplementation significantly reduces systemic inflammatory markers (IL-6, hs-CRP, TNF-α) and improves insulin resistance indices (HOMA-IR) and lipid profiles. However, supplementation alone does not induce significant reductions in body mass index (BMI) or total adipose tissue volume. Furthermore, owing to vitamin D sequestration in adipose tissue and volumetric dilution, patients with obesity require personalized, high-dose regimens (often ≥4,000 IU/day) to achieve optimal serum 25(OH)D levels (30–50 ng/mL) necessary for clinical immunomodulation. Conclusions: While vitamin D is not a standalone weight-loss intervention, it serves as a crucial adjunctive therapy for modulating the LGCI associated with obesity. Current data do not support extrapolating these anti-inflammatory effects to a definitive reduction in cardiometabolic risk. However, achieving optimal serum levels requires personalized dosing to address altered pharmacokinetics, alongside essential lifestyle modifications, including diet and exercise.Keywords
This publication has 30 references indexed in Scilit:
- Low-grade chronic inflammation in young adults: An underrecognized epidicemicEXPLORE, 2026
- Effects of personalized vitamin D3 on inflammation in colorectal cancer patients: a randomized trialBritish Journal of Cancer, 2026
- A meta-analysis of the effects of vitamin D supplementation on endocrine metabolic and inflammatory markers in patients with polycystic ovarian syndromeMedicine, 2026
- Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trialAnnals of Medicine, 2025
- Effects of vitamin K2 and D3 supplementation on epicardial adipose tissue and systemic inflammation: A substudy of the AVADEC trialAtherosclerosis, 2025
- High-dose vitamin D supplementation in pregnancy ameliorates obesity-induced increase in maternal IL-1β level without affecting obesity-induced increase in IL-6 and MCPThe Journal of Steroid Biochemistry and Molecular Biology, 2025
- The effect of active vitamin D supplementation on body weight and composition: A meta-analysis of individual participant dataClinical Nutrition, 2024
- Influence of Vitamin D Supplementation on Growth, Body Composition, and Pubertal Development Among School-aged Children in an Area With a High Prevalence of Vitamin D DeficiencyJAMA Pediatrics, 2023
- Body Mass IndexNutrition Today, 2015
- Obesity and vitamin D deficiency: a systematic review and meta‐analysisObesity Reviews, 2015